fluoxetine targets serotonin
Evidence from:
primary |
all sources
Evidence (2 sources)
Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
(2017)
PMID:28342823
cited
Fluoxetine is an inhibitor of serotonin reuptake, raising serotonin levels.
confidence: 0.94
Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
(2017)
PMID:28342823
cited
Best known for its effect on serotonin reuptake (Fuller and Wong, 1977)
confidence: 0.95